Holen Sie sich die Stockscreener-App
2.65
1.49%
-0.04
Handel nachbörslich:
2.65
Finanzdaten der Vivos Therapeutics Inc-Aktie (VVOS)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
5.26%
3.419
|
3.248 | 3.301 | 3.395 | 3.857 |
| Cost Of Revenue |
0.10
|
- | 0.10 | 0.10 | 0.10 |
| Gross Profit |
0.05%
1.937
|
1.938 | 1.898 | 2.098 | 2.337 |
Operating Expenses
|
8.04%
5.722
|
6.222 | 5.387 | 6.615 | 7.342 |
| Benefits Costs and Expenses |
73.77%
7.182
|
27.38 | - | - | 2.157 |
| Costs And Expenses |
88.06%
7.182
|
3.819 | 6.79 | 7.912 | 2.157 |
| Depreciation and Amortization |
2.01%
0.146
|
0.149 | 0.15 | 0.148 | 0.175 |
| Operating Income/Loss |
11.65%
-3.785
|
-4.284 | -3.489 | -4.517 | -5.005 |
| Income/Loss From Continuing Operations Before Tax |
84.41%
-3.763
|
-24.14 | 3.301 | -5.528 | -1.703 |
| Income/Loss From Continuing Operations After Tax |
11.65%
-3.763
|
-4.259 | -2.093 | -5.528 | -1.703 |
|
Net Income/Loss
|
11.65%
-3.763
|
-4.259 | -2.093 | -5.528 | 1.70 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
3,357%
2.3082
|
0.0668 | 1.1973 | 29.93 | 24.76 |
| Diluted Average Shares |
3,357%
2.3082
|
0.0668 | 1.1973 | 29.93 | -1.6837 |
| Basic Earnings Per Share |
46.56%
-1.63
|
-3.05 | -1.75 | -0.18 | -0.07 |
| Diluted Earnings Per Share |
46.56%
-1.63
|
-3.05 | -1.75 | -0.18 | -0.07 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
0.47%
1.00%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Kapitalisierung:
|
Volumen (24h):